AHR and neoplasm: Elucidating effects of microbiota-derived ligands on AhR activation within CD8+ T cells will not only improve our understanding of the complex relationship between the gut microbiota and the immune system, but it may also help identify novel therapeutic targets for enhancing anti-tumor immunity and improving cancer treatment outcomes.